U.S. market Closed. Opens in 2 hours 46 minutes

BCYC | Bicycle Therapeutics plc Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue26.98M14.46M11.70M10.39M13.80M7.14M2.06MN/A
Cost of Revenue6.47M3.69M44.88M33.15M25.54M20.76M11.87M269.29K
Gross Profit20.51M10.78M-33.18M-22.76M-11.74M-13.62M-9.81M-269.29K
Operating Expenses216.92M131.12M77.31M62.35M40.10M28.88M18.27M13.22M
Selling, General & Admin59.83M49.51M32.44M29.20M14.56M8.12M6.41M3.45M
Research & Development156.50M81.61M44.88M33.15M25.54M20.76M11.87M9.77M
Other Operating ExpensesN/AN/AN/AN/A-5.38M-665.00K-119.00KN/A
Operating Income-189.95M-116.65M-65.62M-51.96M-26.30M-21.75M-16.21M-13.49M
Other Expenses / Income10.74M2.41M-2.86M226.00K-4.56M-496.00K-69.00K-37.90K
Before Tax Income-179.21M-114.24M-68.48M-51.73M-30.86M-22.24M-16.28M-13.53M
Income Tax Expenses1.46M-1.52M-1.66M-724.00K-254.00K-396.00K-23.00K-20.94K
Net Income-180.66M-112.72M-66.82M-51.01M-30.61M-21.85M-16.26M-13.51M
Interest Expenses3.26M3.34M2.98M457.00KN/AN/AN/AN/A
Basic Shares Outstanding35.59M29.66M25.06M19.15M11.05M13.29M13.29M17.70M
Diluted Shares Outstanding35.59M29.66M25.06M19.15M11.05M13.29M13.29M17.70M
EBITDA-183.40M-112.96M-64.08M-50.39M-30.03M-21.49M-15.88M-13.26M
EBITDA Margin-679.86%-781.06%-547.84%-484.98%-217.56%-301.20%-770.92%0.00%
EBIT-175.94M-110.90M-65.50M-51.28M-30.86M-22.24M-16.28M-13.53M
EBIT Margin-652.22%-766.76%-559.96%-493.52%-223.62%-311.69%-790.39%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙